Newsletter - All News

Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research

Category

Continent

From

To

Quotient Sciences and Biorasi Partner to Deliver F...

Quotient Sciences and Biorasi Partner to Deliver F...

Category : Licensing/Collaboration Deal 15 October 2025

Collaboration streamlines transition from first-in-human studies to proof-of-concept Quotient Sci...

Ascletis Pharma Selects ASC35 as Once-Monthly GLP-...

Ascletis Pharma Selects ASC35 as Once-Monthly GLP-...

Category : Clinical Trial Update 13 October 2025

Ascletis Pharma Inc. (HKEX: 1672) has unveiled ASC35, a next-generation GLP-1/GIP dual peptide agoni...

Cidara Therapeutics’ CD388 Receives FDA Breakthrou...

Cidara Therapeutics’ CD388 Receives FDA Breakthrou...

Category : ODD/BTA/FTA Status 13 October 2025

Cidara Therapeutics announced that the U.S. FDA has granted Breakthrough Therapy designation for CD3...

Dr Reddy’s and Zydus Lifesciences Initiate US Reca...

Dr Reddy’s and Zydus Lifesciences Initiate US Reca...

Category : Warning/Recalls 13 October 2025

Dr Reddy’s Laboratories and Zydus Lifesciences are recalling products in the United States due...

FDA Authorizes Emalex Biosciences’ Expanded Access...

FDA Authorizes Emalex Biosciences’ Expanded Access...

Category : Approval/Launch 11 October 2025

Emalex Biosciences today announced that the U.S. Food and Drug Administration (FDA) has authorized t...

‹
1
2

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.